Skip to content
Nonprofiteer
← COLLABORATIVE COMMUNITY ON OPHTHALMIC INNOVATION FOUNDATION

Form 990 for tax year 2025

Filed by COLLABORATIVE COMMUNITY ON OPHTHALMIC INNOVATION FOUNDATION.

Totals

Total revenue
$1,619,910
Total expenses
$211,246
Contributions and grants received
$1,482,932
Grants paid
$0
Program service revenue
$136,674
Investment income
$304
Other revenue
$0
Total assets, end of year
$1,468,527
Total liabilities, end of year
$12,276
Net assets or fund balances, end of year
$1,456,251
Program services expenses (Part IX)
$92,435
Management and general expenses
$114,982
Fundraising expenses
$3,829
Program service expenses (Part III)
$92,435

Program services were 43.8% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1f · All other contributions, gifts and grants

    $1,482,932

  • 2a · Program service revenue: FDA BAA contract income

    total $136,674 · related or exempt $136,674

  • 3 · Investment income

    total $304 · related or exempt $304

  • 4 · Income from investment of tax-exempt bond proceeds

    total $0

  • 5 · Royalties

    total $0

  • 6d · Net rental income or loss

    total $0

  • 7d · Net gain or loss

    total $0

  • 8c · Net income from fundraising events

    total $0

  • 9c · Net income from gaming

    total $0

  • 10c · Net income from sales of inventory

    total $0

  • 11e · Other revenue, total

    $0

Functional expenses

Part IX, the statement of functional expenses.

  • 1 · Grants to domestic organizations and governments

    total $0

  • 2 · Grants to domestic individuals

    total $0

  • 3 · Grants to foreign organizations and individuals

    total $0

  • 4 · Benefits paid to or for members

    total $0

  • 5 · Compensation of officers, directors and key employees

    total $0

  • 6 · Compensation of disqualified persons

    total $0

  • 7 · Other salaries and wages

    total $0

  • 8 · Pension plan contributions

    total $0

  • 9 · Other employee benefits

    total $0

  • 10 · Payroll taxes

    total $0

  • 11a · Fees: management

    total $10,383 · management and general $10,383

  • 11b · Fees: legal

    total $1,438 · management and general $1,438

  • 11c · Fees: accounting

    total $15,561 · management and general $15,561

  • 11d · Fees: lobbying

    total $0

  • 11e · Fees: professional fundraising services

    total $0

  • 11f · Fees: investment management

    total $0

  • 11g · Fees: other

    total $56,207 · program services $36,791 · management and general $19,416

  • 12 · Advertising and promotion

    total $17,714 · program services $6,091 · management and general $11,009 · fundraising $614

  • 13 · Office expenses

    total $320 · management and general $320

  • 14 · Information technology

    total $3,277 · management and general $3,277

  • 15 · Royalties

    total $0

  • 16 · Occupancy

    total $0

  • 17 · Travel

    total $60,907 · program services $10,173 · management and general $50,734

  • 18 · Travel or entertainment for public officials

    total $0

  • 19 · Conferences, conventions and meetings

    total $42,595 · program services $39,380 · fundraising $3,215

  • 20 · Interest

    total $0

  • 21 · Payments to affiliates

    total $0

  • 22 · Depreciation, depletion and amortization

    total $0

  • 23 · Insurance

    total $1,001 · management and general $1,001

  • 24a · Other expenses: Credit card fee

    total $979 · management and general $979

  • 24b · Other expenses: Bank Service Charges

    total $519 · management and general $519

  • 24c · Other expenses: Licenses

    total $345 · management and general $345

  • 24e · All other expenses

    total $0

Balance sheet

Part X, book values.

  • 1 · Cash, non-interest-bearing

    beginning of year $48,178 · end of year $837,752

  • 2 · Savings and temporary cash investments

    end of year $0

  • 3 · Pledges and grants receivable

    beginning of year $20,000 · end of year $423,000

  • 4 · Accounts receivable

    end of year $0

  • 5 · Loans and receivables from officers and key people

    end of year $0

  • 6 · Loans and receivables from disqualified persons

    end of year $0

  • 7 · Other notes and loans receivable

    end of year $0

  • 8 · Inventories for sale or use

    end of year $0

  • 9 · Prepaid expenses and deferred charges

    beginning of year $28,314 · end of year $207,775

  • 10c · Land, buildings and equipment, net

    end of year $0

  • 11 · Investments: publicly traded securities

    end of year $0

  • 12 · Investments: other securities

    end of year $0

  • 13 · Investments: program-related

    end of year $0

  • 14 · Intangible assets

    end of year $0

  • 15 · Other assets

    end of year $0

  • 17 · Accounts payable and accrued expenses

    beginning of year $26,469 · end of year $12,276

  • 27 · Net assets without donor restrictions

    beginning of year $70,023 · end of year $1,456,251

Mission and programs · 2025

Mission

Improve public health by advancing the diagnosis, management, and treatment of eye diseases and related conditions through collaboration across government, academia, patient groups, medical product companies, software and AI developers, and professional organizations.

Activities or mission (Part I)

Improve public health by advancing the diagnosis, management, and treatment of eye diseases and other medical conditions through collaboration, meetings, research initiatives, and stakeholder engagement in ophthalmic innovation.

  • Innovation Symposium and educational convenings: The organization organized and supported educational and stakeholder convenings focused on ophthalmic innovation, including the Stanford Innovation Symposium and related meeting, webinar, registration, planning, marketing, and program-management activities. These activities promoted collaboration among government, academia, patient groups, clinicians, and industry participants.

    Expenses $51,856

  • FDA/BAA program: The organization continued FDA/BAA-related data-discovery and IRIS Registry analysis activities intended to advance visual health equity and real-world evidence initiatives using ophthalmic imaging and artificial intelligence.

    Expenses $31,109 · Revenue $136,674

  • Stakeholder Council and other program services: The organization supported Stakeholder Council and related working-group activities that brought together representatives of government, academia, patient organizations, medical-product companies, software and AI developers, and professional organizations to address ophthalmic innovation priorities.

    Expenses $9,470

As filed on the 2025 return. The filer continues this part on Schedule O, which is not shown here.

Listed in Part VII

  • Malvina Eydelman MD

    CEO

    Total calculated
    $0
    Hours/week
    10
  • Joel Schuman MD

    Chairman

    Total calculated
    $0
    Hours/week
    10
  • Michael Abramoff MD PhD

    Treasurer

    Total calculated
    $0
    Hours/week
    5
  • David Myung MD PhD

    Vice President

    Total calculated
    $0
    Hours/week
    1
  • Mark Blumenkranz MD MMS

    Director

    Total calculated
    $0
    Hours/week
    1
  • Aaron Lee MD

    Director

    Total calculated
    $0
    Hours/week
    1
  • Carol Shields MD

    Director

    Total calculated
    $0
    Hours/week
    1
  • Michael Repka MD

    Director

    Total calculated
    $0
    Hours/week
    1
  • Emily Chew MD

    Director

    Total calculated
    $0
    Hours/week
    1
  • Michelle Tarver MD PhD

    Director

    Total calculated
    $0
    Hours/week
    1
  • Daniel Ting MBBS PhD

    Director

    Total calculated
    $0
    Hours/week
    1
  • Flora Lum MD

    Director

    Total calculated
    $0
    Hours/week
    1
  • Michael Chiang

    Director

    Total calculated
    $0
    Hours/week
    1
  • Deborah O'Keefe

    Director

    Total calculated
    $0
    Hours/week
    1
  • Ted Stiefel

    CFO

    Total calculated
    $0
    Hours/week
    2

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those.

Grants on this return

No itemized grants to organizations on this return.

Provenance

Return type
form_990
Tax year
2025
Filed
15 August 2026
IRS schema version
2025v4.1
Source object
202632279349301108

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.